RICHARD J. HAVEL, M.D.
The disorder most commonly called "type III hyperlipoproteinemia," also referred to as "broad beta," "floating beta disease," or "dysbetalipoproteinemia," has been of great fascination to investigators of the genetically determined disorders of lipid transport in the blood. This fascination relates both to its distinctive clinical features and to the unique very low density lipoprotein (VLD lipoprotein) that accumulates in blood plasma of affected individuals. The reports from Seattle and Bethesda in this issue (pp. 141-174) provide improved criteria for diagnosing the presence of the mutant gene as well as evidence that it may be transmitted as an autosomal Mendelian dominant.
Learn more about subscription options.
Register Now for a free account.
HAVEL RJ. Hyperlipoproteinemia: Problems in Diagnosis and Challenges Posed by the "Type III" Disorder. Ann Intern Med. 1975;82:273–274. doi: 10.7326/0003-4819-82-2-273
Download citation file:
Published: Ann Intern Med. 1975;82(2):273-274.
Cardiology, Coronary Risk Factors, Dyslipidemia.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only